维普期刊资源整合服务平台（V6.5）

93篇 您的检索式：作者名="Robidoux"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial显示文摘	David N Krag Stewart J Anderson Thomas B Julian Ann M Brown Seth P Harlow Joseph P Costantino Takamaru Ashikaga Donald L Weaver Eleftherios P Mamounas Lynne M Jalovec Thomas G Frazier R Dirk Noyes André Robidoux Hugh MC Scarth Norman Wolmark	2010	Lancet Oncology2010，，10：	3
2	Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial显示文摘	David N Krag Stewart J Anderson Thomas B Julian Ann M Brown Seth P Harlow Takamaru Ashikaga Donald L Weaver Barbara J Miller Lynne M Jalovec Thomas G Frazier R Dirk Noyes André Robidoux Hugh MC Scarth Denise M Mammolito David R McCready Eleftherios P Mamo	2007	Lancet Oncology2007，，10：	2
3	Geometric integration using discrete gradients 显示文摘	MC LACHLAN R I QUISPEL G R W ROBIDOUX N	1999	Phil Trans R Soc Lond A1999，357，：	1
4	Evaluation of lapatinib as a component of neoadjuvant therapy for HER -2+ operable breast cancer: nsabp protocol B-41 显示文摘	Robidoux A Tang G Rastogi P	2012	J Clin Oncol302012，30，18：	1
5	Acute and chronic toxicity of the new explosive CL-20 to the earthworm ( Eiseniaan- drei) exposed to amended natural soils显示文摘	RObidoux P Y Sunahara G I Savard K	2004	Environmental Toxi- cology and Chemistry2004，23，4：	1
6	phaseⅡneoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer显示文摘	Robidoux A Buzdar AU Quinaux EA	2010	Clin Breast Cancer2010，10，1：	1
7	Requirement of vimentin filament assembly for beta 3-adrenergic receptor activation of ERK MAP kinase and lipolysis 显示文摘	Kumar N Robidoux J Daniel K W	2007	Biol Chem2007，282，：	1
8	Requirement of vimentin filament assembly for beta3 adrenergic receptor activation of ERK MAP kinase and lipolysis显示文摘	Kumar N Robidoux J Daniel KW	2007	J Biol Chem2007，282，：	1
9	p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene显示文摘	Cao W Daniel K W Robidoux J	2004	Mol Cell Biol2004，24，7：	1
10	Geometric integration using discrete gradients显示文摘	Quispel G R W Robidoux N	1999	Phil Trans R Soc Lond A1999，357，：	1
11	Selective activation of MAP kinase kinase-3 and p38 MAP kinase is essential for cAMP-dependent UCP1 expression in adipocytes显示文摘	Robidoux J Cao W Quan H	2005	Mol Cell Biol2005，25，13：	1
12	β -Adrenergic receptors and regulation of energy expenditure:a family affair显示文摘	Robidoux J Martin TL Collins S	2004	Annu RevPharmacol 7oxicol2004，44，：	1
13	Reduced antioxidant capacity and diet-induced athereselerosis in uncoupling protein-2-deficient mice显示文摘	Moukdar F Robidoux J Lyght O	2009	J Lipid Res2009，50，1：	1
14	Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers显示文摘	Gronwald J Robidoux A Kim-Sing C	2014	Breast Cancer Res Treat2014，146，2：	1
15	Automated Mo- deling of Dynamic Reliability Block Diagrams Using Colored Petri Nets显示文摘	Robidoux R Xu Haiping Xing Liudong	2010	IEEE Transactions on Systems Man and Cybernetics2010，40，2：	1
16	E5531, A pure endotoxin antagonist of high potency 显示文摘	Asano O Robidoux AL	1995	Science1995，268，5207：	1
17	Maximal beta3-adrenergic regulation of lipolysis in- volves Src and epidermal growth factor receptor-de- pendent ERK1/2 activation显示文摘	ROBIDOUX J KUMAR N DANIEL K W	2006	J Biol Chem2006，281，37：	1
18	Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by oleic acid显示文摘	Medvedev AV Robidoux J Bai X	2002	J Biol Chem2002，277，42：	1
19	Technetium-99m-sesta mibiprone Scintimammography to detect primary breast cancer and axillary lymph node involvement显示文摘	TAILLEFER R ROBIDOUX A LAMBERST R	1995	J Nucl Med1995，36，10：	1
20	Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast can- cer (NSABP protocol B-41): an open label, randomised phase 3 trial 显示文摘	Robidoux A Tang G Rastogi P	2013	Lancet Oncol2013，14，12：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示